News

Foresight Group Holdings (FSG.L) is featured among the top 10 penny stocks worldwide. Its share price stands at £4.115, with a market capitalization of £469.18 million, and it has earned a financial health rating of ★★★★★★. The company’s operations are described as stable, supported by seasoned management that has maintained consistent performance....

Full article

Domino's Pizza Group (DOM.L) is noted as a promising small‑cap stock, with a market capitalisation of approximately £1.67 billion. The company, a leading pizza delivery and carry‑out operator, derives most revenue from franchisee sales and national advertising. Despite high debt and dependence on external borrowing, earnings are projected to grow 3...

Full article

Peers in the diversified financial‑services space show mixed results: Corpay reported a 20.7 % year‑on‑year revenue increase, while WEX saw revenues rise 5.7 %. DFIN’s stock has lagged its peers, falling 26.4 % over the past month. The average analyst price target stands at $64.33, compared to the current share price of $39.12.

Full article

For the upcoming report, analysts project revenue to be flat year‑on‑year at $155.3 million, with adjusted earnings of $0.41 per share. Over the last 30 days, analysts have largely reaffirmed these figures, indicating confidence in the company’s trajectory.

Full article

Donnelley Financial Solutions (NYSE: DFIN) is slated to release its earnings on Tuesday before the market opens. The previous quarter ended with revenues of $175.3 million, a 2.3 % decline year‑over‑year, yet the company beat analysts’ revenue expectations by 3.3 %. Despite this, DFIN has missed Wall Street revenue estimates five times in the past...

Full article

United Parks & Resorts (PRKS) has reported continued struggles in visitor performance relative to industry peers, a key driver of its revenue growth. Over the past two years, the company’s free cash flow margin has declined to 11.8%, constraining capital available for expansion and share repurchase activity. The firm’s current investment decisions...

Full article

Krispy Kreme (DNUT) trades at $2.97 per share and is one of the stocks highlighted among those priced below $10. The fast‑food chain’s earnings per share have fallen over the last four years, prompting concerns that its long‑term growth prospects are weak. Cash burn remains high, and the company’s short cash runway increases the probability of a ca...

Full article

Overall, the firm’s commercial traction with Casgevy, combined with a growing pipeline and a projected lift in 2026 revenue, remains the central narrative driving investor interest, while the sizable quarterly and annual losses, reliance on Vertex, and the recent equity issuance temper expectations of short‑term profitability.

Full article

CRISPR Therapeutics continues to broaden its pipeline through collaborations with Vertex and Sirius Therapeutics. New candidates include CTX310 (cardiovascular), CTX611 (thromboembolic), a refractory hypertension therapy, treatments for alpha‑1 antitrypsin deficiency affecting lung and liver disease, and several autoimmune disease indications. The...

Full article

Casgevy sales in 2025 totaled $116 million, surpassing Vertex’s target of approximately $100 million, a performance that prompted Needham to lift its price target on CRISPR Therapeutics from $80 to $82 while maintaining a Buy rating. The firm’s share price has declined 6.7% over the past 30 days, sits about 37% below analyst targets, and trades rou...

Full article